Core Laboratories (CLB) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Oct 31, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, latest quarter: NoneNo large changes
Federal contractsUSAspending.gov, last 12 months: No awardsNone on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about CLB filings

Are insiders buying or selling Core Laboratories NV (CLB) stock?

Neither. Core Laboratories NV (CLB) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded CLB recently?

None. No member of Congress disclosed a CLB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CLB smart-money data?

This summary uses filings available on Oct 31, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on CLB

Lean long1 source:
- Insiders
Lean short1 source:
- Politicians

Top traders
No tracked positions at the last update
Insiders
- Lawrence Bruno, bought $53.9K, open market, filed Aug 4
Lean long · thin1 buy · $53.9K
Form 4 filings, open market.
Politicians
- Donald Trump, President, sold $1K–$15K, disclosed Sep 22
- Donald Trump, President, sold $1K–$15K, disclosed Jul 1
Lean short · thin0 buys · 2 salesExecutive
Executive branch filings. Amounts are filing ranges, not prices, and filings can lag the trade.
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about CLB filings

Are insiders buying or selling Core Laboratories NV (CLB) stock?

Neither. Core Laboratories NV (CLB) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded CLB recently?

None. No member of Congress disclosed a CLB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CLB smart-money data?

Insiders

What insiders are doing

1 trade · 6 mo

Bought$54K

Buys (1)

BL
Bruno Lawrence
Chairman and CEO · Aug 4
$54K
bought
Signals like this: n=2386, 51% finished lower at D15, median -0.3% vs SPY +0.3%

Unlock everything for $29/month

Unlock for $29/month

Reported Oct 28, 2026

Earnings came in 5.9% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Oct 28, 2026

Period ending

Sep 30, 2026

Earnings per share

$0.16-5.88% miss

$0.17 expected

Revenue

$132.1M

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Oct 28, 2026	$0.16est. $0.17	-5.88%miss	$132.1MSEC filing	-1.8%from $134.5M
Jun 30, 2026Reported Jul 29, 2026	$0.11est. $0.08	+$0.03beat	$124.6MSEC filing	-4.3%from $130.2M
Mar 31, 2026Reported Apr 29, 2026	$0.06est. $0.11	-45.45%miss	$121.8MSEC filing	-1.4%from $123.6M
Dec 31, 2025Reported Feb 4, 2026	$0.21est. $0.19	+10.53%beat	$526.5M · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Oct 22, 2025	$0.22est. $0.19	+15.79%beat	$134.5MSEC filing	+0.1%from $134.4M
Jun 30, 2025Reported Jul 23, 2025	$0.19est. $0.18	+5.56%beat	$130.2MSEC filing	-0.3%from $130.6M
Mar 31, 2025Reported Apr 23, 2025	$0.14est. $0.15	-6.67%miss	$123.6MSEC filing	-4.7%from $129.6M
Dec 31, 2024Reported Jan 29, 2025	$0.22est. $0.22	+0.00%in line	$523.8M · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $10.36
52-wk high: $20.32
High: $10.79
52-wk low: $9.13
Low: $10.22
Prev close: $10.40
Mkt cap: $477.2M
P/E: 20.0x
ROE: +9.0%
Fwd P/E: 19.8x
Beta: 1.14
P/S: 0.9x
P/B: 1.8x
Profit margin: +4.7%
Op margin: +7.4%

Fundamentals

Is the business strong?

Fairly priced and running thin margins.

Net margin: 4.7%
P/E: 20.00
Forward P/E: 19.76
Market cap: $477M

Valuation

P/S0.92
P/B1.76
Dividend yield0.0%

Quality

Operating margin7.4%
ROE9.0%
ROA4.5%

Growth

Beta1.14

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

60balanced

20D volatility

47%annualized

52-week range

$10.64

$9.13$20.32

20D support

$9.13recent floor

20D resistance

$10.79recent ceiling

Returns

5D +7.4%20D +7.3%60D -4.8%

Price vs moving averages

SMA20 +5.0%SMA50 -3.2%SMA200 -23.2%

Volume pace

1.17xvs prior 20D

Smart money at a glance

Filings to Oct 31, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, latest quarter: NoneNo large changes
Federal contractsUSAspending.gov, last 12 months: No awardsNone on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about CLB filings

Are insiders buying or selling Core Laboratories NV (CLB) stock?

Neither. Core Laboratories NV (CLB) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded CLB recently?

None. No member of Congress disclosed a CLB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CLB smart-money data?

Smart money on CLB

Lean long1 source:
- Insiders
Lean short1 source:
- Politicians

Top traders
No tracked positions at the last update
Insiders
- Lawrence Bruno, bought $53.9K, open market, filed Aug 4
Lean long · thin1 buy · $53.9K
Form 4 filings, open market.
Politicians
- Donald Trump, President, sold $1K–$15K, disclosed Sep 22
- Donald Trump, President, sold $1K–$15K, disclosed Jul 1
Lean short · thin0 buys · 2 salesExecutive
Executive branch filings. Amounts are filing ranges, not prices, and filings can lag the trade.
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about CLB filings

Are insiders buying or selling Core Laboratories NV (CLB) stock?

Neither. Core Laboratories NV (CLB) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded CLB recently?

None. No member of Congress disclosed a CLB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CLB smart-money data?

Insiders

What insiders are doing

1 trade · 6 mo

Bought$54K

Buys (1)

BL
Bruno Lawrence
Chairman and CEO · Aug 4
$54K
bought
Signals like this: n=2386, 51% finished lower at D15, median -0.3% vs SPY +0.3%

Unlock everything for $29/month

Unlock for $29/month

Reported Oct 28, 2026

Earnings came in 5.9% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Oct 28, 2026

Period ending

Sep 30, 2026

Earnings per share

$0.16-5.88% miss

$0.17 expected

Revenue

$132.1M

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Oct 28, 2026	$0.16est. $0.17	-5.88%miss	$132.1MSEC filing	-1.8%from $134.5M
Jun 30, 2026Reported Jul 29, 2026	$0.11est. $0.08	+$0.03beat	$124.6MSEC filing	-4.3%from $130.2M
Mar 31, 2026Reported Apr 29, 2026	$0.06est. $0.11	-45.45%miss	$121.8MSEC filing	-1.4%from $123.6M
Dec 31, 2025Reported Feb 4, 2026	$0.21est. $0.19	+10.53%beat	$526.5M · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Oct 22, 2025	$0.22est. $0.19	+15.79%beat	$134.5MSEC filing	+0.1%from $134.4M
Jun 30, 2025Reported Jul 23, 2025	$0.19est. $0.18	+5.56%beat	$130.2MSEC filing	-0.3%from $130.6M
Mar 31, 2025Reported Apr 23, 2025	$0.14est. $0.15	-6.67%miss	$123.6MSEC filing	-4.7%from $129.6M
Dec 31, 2024Reported Jan 29, 2025	$0.22est. $0.22	+0.00%in line	$523.8M · FYSEC filing	No year-ago quarter

Open: $10.36
52-wk high: $20.32
High: $10.79
52-wk low: $9.13
Low: $10.22
Prev close: $10.40
Mkt cap: $477.2M
P/E: 20.0x
ROE: +9.0%
Fwd P/E: 19.8x
Beta: 1.14
P/S: 0.9x
P/B: 1.8x
Profit margin: +4.7%
Op margin: +7.4%

Fundamentals

Is the business strong?

Fairly priced and running thin margins.

Net margin: 4.7%
P/E: 20.00
Forward P/E: 19.76
Market cap: $477M

Valuation

P/S0.92
P/B1.76
Dividend yield0.0%

Quality

Operating margin7.4%
ROE9.0%
ROA4.5%

Growth

Beta1.14

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

60balanced

20D volatility

47%annualized

52-week range

$10.64

$9.13$20.32

20D support

$9.13recent floor

20D resistance

$10.79recent ceiling

Returns

5D +7.4%20D +7.3%60D -4.8%

Price vs moving averages

SMA20 +5.0%SMA50 -3.2%SMA200 -23.2%

Volume pace

1.17xvs prior 20D

Core Laboratories NV

Smart money at a glance

What do analysts expect?

Questions about CLB filings

Smart money on CLB

Questions about CLB filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 5.9% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Core Laboratories NV

Smart money at a glance

What do analysts expect?

Questions about CLB filings

Smart money on CLB

Questions about CLB filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 5.9% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Core Laboratories NV

Overview

Questions about CLB filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Core Laboratories NV

Overview

Questions about CLB filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.